NEU 1.02% $15.12 neuren pharmaceuticals limited

Ann: Q2 2023 quarterly activity and cash flow report, page-5

  1. 501 Posts.
    lightbulb Created with Sketch. 287
    Morning everyone, great quarterly!

    Most important takeaway for me is that the PMS Phase 2 trial results are still on track for a December 2023 readout.

    Also, I’ll be listening to Acadia’s earnings call later this week and will share anything noteworthy. The actual Q2 Daybue sales should be announced and possibly updated guidance for Q3 sales.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.12
Change
-0.155(1.02%)
Mkt cap ! $1.930B
Open High Low Value Volume
$15.38 $15.47 $14.93 $4.149M 275.3K

Buyers (Bids)

No. Vol. Price($)
13 1252 $15.11
 

Sellers (Offers)

Price($) Vol. No.
$15.12 1693 19
View Market Depth
Last trade - 14.21pm 30/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.